Problem

Circular Genomics is developing blood-based biomarker tests using circular RNA to detect Alzheimer’s disease earlier than current methods.

The science is compelling: circular RNAs are stable, brain-enriched molecules that can cross the blood-brain barrier and be detected in blood. Changes in their levels reflect early patterns of neuronal and inflammatory dysregulation – potentially before symptoms even appear.

But explaining this to investors? That was the challenge.

How do you make circular RNA – a molecule most people have never heard of – feel simple and investable?

Solution

We created an investor pitch animation that walks through the science step by step.

The animation shows:

  • Why current Alzheimer’s detection methods often come too late
  • What makes circular RNA different from linear RNA (stable, closed-loop structure)
  • How circular RNAs cross the blood-brain barrier and can be measured in blood
  • Why this enables earlier detection and better patient outcomes

Short. Visual. Easy to follow before or during an investor meeting.

Results

“The team did an outstanding job bringing the science to life through clear storytelling and thoughtful animation. The result is a video that is engaging, informative, and approachable for a broad scientific audience.”
– Olivia Tucker, Circular Genomics

“This was validated after sharing the video with a world-leading Alzheimer’s researcher, who commented on how informative and effective it was as an introduction to circular RNA.”
— Olivia Tucker, Circular Genomics

Need an investor pitch animation for your biotech?

We help biotech companies explain complex science in 90 seconds. Book a call to see if an investor pitch animation could work for your next raise.